Phase 1 study of the histone deacetylase inhibitor entinostat plus clofarabine for poor-risk Philadelphia chromosome-negative (newly diagnosed older adults or adults with relapsed refractory disease) acute lymphoblastic leukemia or biphenotypic leukemia
Year: 2021
Type: article
Study design: Clinical Trial
Source: Leukemia Research
Authors: Hetty E. Carraway, Yazeed Sawalha, Ivana Gojo, Min-Jung Lee, Sunmin Lee, Yusuke Tomita, Akira Yuno, Jackie Greer, B. Douglas Smith, Keith W. Pratz, Mark J. Levis, Steven D. Gore, Nilanjan Ghosh, Amy Dezern, Amanda L. Blackford, Maria R. Baer, Lia Gore, Richard Piekarz, Jane B. Trepel, Judith E. Karp
Institutions: Cleveland Clinic, The Ohio State University Wexner Medical Center, Johns Hopkins University, Johns Hopkins Hospital, Sidney Kimmel Comprehensive Cancer Center, National Institutes of Health, National Cancer Institute, Center for Cancer Research, University of Pennsylvania, Carolinas Healthcare System, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Colorado Cancer Center
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3200224382